The North American COVID-19 diagnostics industry will see the considerable decline of 24.7% during the forecast period. North America is anticipated to make huge contribution to the global COVID-19 diagnostics market in 2020; however, the market will decline during the forecast period. In the US, CDC is collaborating with commercial laboratories to perform and publish results from a large-scale geographic seroprevalence survey that has tested de-identified clinical blood specimens from Connecticut, Louisiana, Minnesota, Missouri, New York City, Philadelphia, San Francisco, South Florida, Utah and Western Washington State for SARS-CoV-2 antibodies. The US conducted studies in 10 sites from March 23, 2020, to May 12, 2020, which aimed to test nearly 1,800 samples collected from each of these 10 areas, nearly every 3–4 weeks. As per the results of the data from CDC partnership with commercial laboratories to test de-identified clinical blood specimens for antibodies in Connecticut, South Florida, the New York City area, Missouri, Utah, and western Washington state, it was found that SARS-CoV-2 infections may be 10 times higher than the reported number of cases.

A full Report of North American COVID-19 Diagnostics Market Available at: https://www.omrglobal.com/industry-reports/north-american-covid-19-diagnostics-market

In April 2020, the US National Institutes of Health (NIH) announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for COVID-19. The program aims to increase the US capacity for SARS-CoV-2 testing. The Ontario COVID-19 Rapid Research Fund is offering colleges, universities, research institutes and academic hospitals with funding to contribute to global efforts to contain the COVID-19 pandemic by making research related to new diagnostics procedure. Abbott Laboratories Inc., Adt Biotech Sdn Bhd, Beckman Coulter Inc., and Cellex Inc. are some of the key players operating in the region. The considerable presence of major market players in the region is further anticipated to propel the market growth.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-covid-19-diagnostics-market

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in base year?
• Which segment/region will project fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test
• Serology Test
• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes

North American COVID-19 Diagnostics Market – Segmentation by Geography

• US
• Canada

Company Profiles

• Abbott Laboratories Inc.
• Beckman Coulter, Inc.
• Cellex Inc.
• Cepheid Inc.
• Chembio Diagnostics Systems Inc.
• Epitope Diagnostics, Inc.
• Hologic Inc.
• Laboratory Corp. of America Holdings
• Luminex Corp.
• PerkinElmer, Inc.
• Quidel Corp.
• Thermo Fisher Scientific, Inc.:

For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/north-american-covid-19-diagnostics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404